Our Partners
Abbvie
We care deeply for patients and customers, their families, our employees, and our communities. We strive to always do the right thing, pursuing the highest standards in quality, compliance, safety, and performance. We embrace diverse backgrounds and perspectives and treat everyone equally, with dignity and respect, allowing us all to achieve our best.
Our commitment to health doesn’t stop with our medicines. Each day, we work to deliver sustainable solutions that improve the health of our business and the health of humankind
ACM Laboratoire Dermatologique
ACM is an independent French laboratory founded in 2001. As a dermatology specialist, ACM Laboratoire dermatologique was created from the desire to offer products capable of treating the most common issues dermatologists are consulted for and which are suitable for all skin types.
ACM develops and markets medicines, cosmetic products, food supplements and medical devices, offering innovative solutions for the most commonly dermatology needs, like hair and nail beauty and health, epidermal hyper and hypo pigmentation, cutaneous aging, oily and imperfection-prone skin, damaged and irritated skin, sensitive skin, dry skin, sun protection, skin folds and irritated skin subject to maceration, Molluscum Contagiosum.
ACM is working closely with skin experts, dermatologists, biologists, and chemists, demanding scientific and pharmeutical rigour at all times. Products are developed and manufactured in France, all active ingrediends being carefully selected in order to be efficient and well tolerated by all.
Since 2013 when our partnership with ACM has begun, we are a Top 10 brand in the dermo-cosmetic romanian market.
ALKALOID
For more than 7 years, we have built a strong and trusted partnership, with good results for both companies. Due to Alkaloid quality products (Caffetin and Magnesium 400 + B complex), we were able to bring in the Romanian pharmaceutical market, safe and efficient products, for our consumers.
Arkopharma
Arkopharma is a pharmaceutical laboratory specialized in the field of phytotherapy. Arkopharma is now the European leader in natural plant-based medications and dietary supplements. Our partnership for Forcapil is a success story, becoming one of the most wanted brand in hair care market.
Biocodex
Biocodex is an independent multinational pharmaceutical company built on high-standards science and manufacturing, with six decades of proven success.
Founded in 1953, the company’s initial focus was gastroenterology featuring a unique probiotic Saccharomyces boulardii CNCM I-745® (Enterol®), the first probiotic drug of its kind that has a positive effect on the gut’s microflora.
Today, Biocodex has transformed itself beyond its probiotic drug roots, expanding its portfolio into a multitude of therapeutic areas.
Our successful partnership has been established in 2011.
Biocodex portfolio of products in Bulgaria includes brands like Enterol®, Otipax®, Stresam® and Stimol®.
Capricorn Life Sciences
Capricorn Life Sciences provides pharmaceutical products with clinically proven efficacy and valuable USP’s in a broad range of therapeutic indications for marketing and distribution or in-licensing. Our partnership started in 2019 with Microduo brand.
Curtis Health Caps
Curtis Health Caps (CHC) is a global CDMO (Contract Development & Manufacturing
Organisation) with over 30 years' experience in the industry.
The company specialises in contract manufacturing of soft gelatin capsules and non-sterile
liquid dosage forms. In addition, CHC offers R&D services. Our cooperation started in 2013 and
applies to brands such as Bobik or Evital.
CHEPLA PHARM
Cheplapharm is a family-owned pharmaceutical company, headquartered in Germany. With an internationally oriented buy-and-build strategy, the family-owned company generates annual growth rates. The close cooperation with their partners and subsidiaries enables CHEPLAPHARM to successfully implement the corporate strategy.
Our partnership with Cheplapharm started in 2016 and covers therapeutic areas of obesity, oncology and post surgery .
Dr. Wolff-Group
MagnaPharm and Dr. Wolff-Group have entered into an Exclusive Distribution and Promotion Agreement of Dr. Wolff’s brands in the territory of Poland. Partnership is covering distribution and promotion of brands Arilin Rapid and Vagisan. The brand Vagisan® comprises medicinal products, medical devices and cosmetics to support women in their wellbeing and the maintenance of the health state of their intimate region. Vagisan is the market leader for intimate care in Germany and its products are recognized by their high quality and efficacy. Arilin Rapid is high quality metronidazole short-term treatment with improved efficacy and tolerability. Dr. Wolff with its women healthcare portfolio is established as partner of gynecologists community in Germany and other markets of Europe, well recognized for efficacy and high quality of its products. MagnaPharm is one of leading players in both, Rx and OTC segments of pharmaceutical market in CEE and offers an excellent platform to further grow Dr. Wolff women healthcare franchise.
Expanscience
Laboratoires Expanscience is an independent family owned French pharmaceutical and dermo-cosmetics laboratory, that develops and manufactures innovative osteoarthritis and skincare products. Expanscience is the first French pharmaceutical and dermo-cosmetic laboratory to be certified B Corp (in 2018) and assessed as ‘Exemplary’ through the “Committed to CSR” label (in 2013, in 2016 and again in 2020). Mustela® is a brand of Laboratoires Expanscience. Mustela® is the skincare expert for babies, children and mothers-to-be with 70 years of research in neonatal dermatology, offering natural dermo cosmetic, eco-friendly products tailored to the needs of the delicate and fragile skin of newborn, babies, children, pregnant women and young mothers. The efficacy and safety of its products has always been an absolute priority for Mustela® – high tolerance formulas that contain 95% natural ingredients on average and that exclude “red” list of ingredients for safe use from birth on; new generation formulas, 100% clinically tested and adapted to each skin type (normal, dry, sensitive and atopic). Because becoming a parent is a very happy occasion, but also gives rise to lots of questions, Mustela® provides personalized services and expert advice to new parents. And because taking care of infants also means protecting their living environment, Mustela® makes every effort to minimize the impact of its product on humans and their environment.
Mustela® brings particular care to the well-being and sensory awareness of babies thanks to a mythical scent and pleasant textures for all of its ranges.
Our successful partnership started in 2010 and since than we continue to support this fantastic brand, that has had an impact on more than 3 generations of babies and mothers all over the world.
GE
General Electric Healthcare
GE Healthcare is an important supplier of medical imaging solutions worldwide, being present in this industry for over 100 years. We started our collaboration in January 2011 and since then we have been constantly expanding the project. The General Electric Healthcare portfolio includes contrast mediums used in x-ray imaging and magnetic resonance imaging.
HRA Pharma
Our jurney with HRA Pharma started in 2014, with an important brand in the Emergency Contraception Market – EllaOne.
Kwizda Pharma
Kwizda Pharma is an international, family run Austrian company with focus on developing, manufacturing and promoting of innovative self-medication and selected therapeutic portfolios. Kwizda Pharma develops and promotes innovative self-medication portfolios to strengthen and expand its leading home market position and to offer modern products to its distribution partners in promising European countries and beyond. Kwizda leading brands are Bronchostop, Leaton, Cranberry UroForte and Biogelat UroAcut/UroProtect. Bronchostop itself was among top 4 fastest growing consumer healthcare brands in Europe in 2013-2017. For more information, please visit www.kwizda-pharma.at
LABO International
Labo International, a Swiss trademark registered in 1989, is pursuing the mission of devoting heavy investments to research to find and patent innovative cosmetic products that are highly beneficial for the consumer.
Our partnership started in 2017 with Crescina and Fillerina brands and year by year we strenghted our partnership by introducing new ranges as Cadu-Crex, Follicular Islands & Fillerina 932 on the local market.
http://crescina.ro/, https://fillerina.ro/, https://cadu-crex.ro/
LENUS PHARMA
Lenus Pharma aims to satisfy human expectations. The philosophy of the company is to develop innovative products, meeting unmet medical needs, using evidence-based medicine. Our strategic partnership with Lenus Pharma started in 2012 with PROfertil and in 2019 with Menopearl.
Pierre Fabre Dermo Cosmetique
Our strategic partnership with Pierre Fabre Group in Romania started back in 1997 when Klorane, Galenic and Ducray entered the market. That was the start point of dermo-cosmetic category in pharmacies.
In 2020 Pierre Fabre Dermo-Cosmetique is the leading* producer of dermo-cosmetic category in Romania. At this point we are present in this market with 7 brands: Eau Thermale Avene No.1* brand in dermo-cosmetic market , Laboratoires Klorane, Ducray, Galenic, A-derma, Elancyl and Rene Furterer.
In 2008 Pierre Fabre Oral Care entered Romanian pharmacy market with a complete portfolio for oral hygiene and care for daily use and treatment.
The story of Pierre Fabre Laboratories began in 1951 with a small-town pharmacy. Mr. Pierre Fabre embarked on an endeavor to develop plant-based products – drugs, family healthcare solutions and dermo-cosmetic products, all derived from the plant kingdom.
Inventor of dermo-cosmetics almost 60 years ago, he created and developed dermo-cosmetic care products with high added value, acting to simultaneously promote the health and beauty of the skin and hair.
The Pierre Fabre Group is simultaneously a botanist, a grower and a manufacturer for its brands (A-Derma, Ducray, Eau Thermale Avène, Elancyl, Galénic, Klorane, René Furterer).
This original position within the cosmetics industry means that they can control the product life cycle, from the plant to the skin and the hair, whether healthy or damaged.
With 6 research centers in France and more than 300 dermo-cosmetics research experts, the Group identifies new targets, develops new natural extracts and designs new textures.
The Pierre Fabre Group has developed a knowledge and expertise chain which lets us control all the steps involved in the product design of our dermo-cosmetics brands.
The end-to-end dermo-cosmetics design process revolves around four combined skills to guarantee the reliability and effectiveness of our products: the identification of plant-based and biotechnological active, ingredients, formulation, packaging, efficacy and safety tests.
Innovation milestones
In 2009, after more than 10 years of research and development, the Pierre Fabre Group perfected the D.E.F.I (Device for Exclusive Formula Integrity) packaging innovation for sterile cosmetics.
D.E.F.I is the first patented closure system that protects sterile formulas from all microorganisms. A packaging innovation still commended in 2018 with the award of 2 packaging Oscars.
The development process is based on a pharmaceutical culture and our dermo-cosmetic care products are not exempt from the fundamental rules of medical and pharmaceutical rigor which require that nothing is claimed without having been proven.
To guarantee that all our formulas are safe and harmless, we perform particularly stringent tests, beyond what is required by European legislation: in vitro pre-clinical tests, in vivo clinical tolerance tests
Every year, more than 1,000 tests and clinical studies are conducted in humans.
2013
Xéracalm A.D., an innovation derived from Thermal Spring Water
Pierre Fabre joined forces with the Oceanological Observatory in Banyuls to explore the composition of Avène spring water. They discovered a unique microflora: Aqua dolomiae. Researchers managed to turn it into an active ingredient with exceptional soothing properties – the future signature ingredient of the XéraCalm A.D. range to relieve itching caused by dry skin.
2014
Hemangiol, a dermatology innovation for infants
At the university hospital in Bordeaux, Dr. Christine Labrèze observed a spectacular improvement in the cutaneous vascular proliferative lesions of an infant treated with Propranolol for a heart problem. In response to the hospital’s request, Pierre Fabre created a pediatric version of Propranolol and conducted a vast clinical study to confirm its efficacy. Hemangiol was launched in 2014.
The Pierre Fabre Laboratoires purpose is drawing relentless inspiration from nature and plants, and by placing pharmaceutical ethics at the very heart of our operations.
Every time we care for a single person, we make the whole world better.
*Smart Data Research Value in Romania. Jan-Dec 2019
Pierre Fabre Medicament
The Pierre Fabre Group is a pioneer on the French industrial scene, with subsidiaries in 45 countries and 3 business lines: pharmaceuticals, family health care and dermo-cosmetics.
Pierre Fabre Group makes oncology a major priority starting with the launch of a chemotherapy product derived from the Madagascar periwinkle.
MagnaPharm’s team has been managing the oncology portfolio since 2015, proving impressive growth results.
Our partneship with Pierre Fabre Medicament also covers products for venous insufficiency, hemorrhoidal disease, feriprive anemia, infantile haemangioma
LYSASKIN Laboratoires
LYSASKIN is a French Dermo-Cosmetic Laboratory, whose vocation is to research and develop product innovations to relieve skin problems.
Lysaskin products are developed and manufactured in France in close colaboration with the most important dermatologists and cosmetologists in France.
Its main area of expertise is dry skin. Our range includes products for almost all stages of cutaneous dryness: from dry skin to severe dryness, calluses, atopic and psoriatic skin.
Our partnership with LYSASKIN started in 2013.
Mylan
Mylan is one of the top pharmaceutical companies in the world. Our strategic partnership with Mylan started back in 2015 in Romania with Cystistat, a medical device used for bladder disease. Today’s portfolio also covers oncology treatments.
NTC
NTC focuses on developing novel pharmaceuticals in ophthalmology through innovative thinking and technology, with care for people. NTC is focused on research and development with over 30 development projects in ophthalmology, of which 10 are pharmaceutical products.
Our partnership with NTC started in 2019. The first products are Vitreonorm, EdeDay, EdeNight.
Omikron Italia
Omikron is an Italian company, specialized in products dedicated to ophthalmology. The products are modern, innovative (International patent holder for citicoline in ophthalmic solution) with many published clinical studies.
Our partnership with Omikron Italia started in 2019, and represents the launch of MagnaPharm’s Ophthalmology divizion.The products are OMK1, OMK2 and Neukron Ofta mese.
Reckitt Benckiser
Reckitt Benckiser is a leading global consumer health and hygiene company. Established more than 200 years ago, the company has gained extensive experience in developing and manufacturing products that people in more than 200 countries trust.
Our partnership started in 2003 with marketing and sales of Nurofen and Strepsils on the Bulgarian pharmaceutical market. Over the years we progressively expanded the product portfolio and provided a wide range of OTC products for cold and flu, pain relief and sore throat. A few years later, in 2010 we entered in another therapeutic area with Gaviscon and provided dual relief of heartburn and indigestion.
Nowadays, thanks to the professional cooperation, we have the opportunity to offer effective OTC products for people of all ages on the local market.
Rominko Pharma
Rominko was established as a trading company, in Bucharest in 1991. We started our partnership with Rominko in 2012. The therapeutic area covered is local treatment of intimate infections.
ROMLA
Launched in October 2017 at the National Dermatology Congress, this collaboration immediately became a success. Ever since, we have been aiming to implement a prevention mindset and keep pain away under the motto “It doesn`t have to hurt!”
Sylphar
Sylphar is a Belgium-based company developing and marketing OTC products worldwide. Sylphar focuses on bringing innovative and consumer friendly products to the global market. Sylphar is presented in Bulgaria by the leading brand iWhite, offering teeth whitening products. The purpose of iWhite’s products is to make your teeth whiter and remove stains on your teeth. All iWhite products are hydrogen peroxide-free, clinically tested and 100% safe. The products are easy to use at home. The brand was launched in Bulgaria in 2014.
TEVA
Teva Pharmaceuticals is the world leader in the production of generic drugs and ranks among the top 15 pharmaceutical companies worldwide.
In May 2019 our company became the partener of Teva Romania for a large number of portfolios including prescription drugs & OTC products.
The prescristion drugs included in Magnapharm’s portfolio are covering areas like respiratory disease, parkinson, rheumatoid arthritis, oncology and HIV.
An important area of the partnership with Teva Romania is represented by the OTC product portfolio. We are building a strategy to increase visibility of Teva OTC products, a portfolio that covers very common need among patients: pain, colds & flu, anti-platelet agent and chronic venous insufficiency. In addition, we are working to increase the market share for two extremely popular products among families with babies: Infacol – for colic babies and Sudocrem – protects and cares for the delicate skin of the baby.
UCB
10 Years of performance and impeccable business development are the reason why MagnaPharm & UCB partnership is one of the major pillars of our company.
The UCB portfolio allergies that we are focusing on made this success story possible.
UCB’s ambition is to transform the lives of people living with severe diseases..
Upsa
Our strategic partnership with UPSA started in 1994. Fervex was the first sachet in cold and flu market, launched in Romania since the beginning of our cooperation. Upsa is present in the Romanian market with 3 important brands: Fervex, Efferalgan and Upsavit.
Union Swiss
Union Swiss is a South African producer, well known globally for it’s beloved brand Bio-Oil. Our partnership started in 2014 and we are proud to be among more than 200 countries that brings into consumers lifes such an amazing brand.
VEMEDIA
A fresh partnership that started in 2018, with a fast growing perspective. Excilor is a strong brand in Europe, preparing to become the same in Romania. Vemedia is a fast growing consumer health company.
VISUFARMA B.V.
VISUfarma is a pharmaceutical company specialized in ophthalmology, with a clear mission: to bring global innovation in European ophthalmology. The company’s mission is to make a visible difference to eye health throughout Europe.
The partnership withVISUfarma started in 2019. VISUfarma is bringging to Romania the Xailin range and VisuXL, covering a wide range of dry-eye products.
Theramex
Theramex, is a global speciality pharmaceutical company solely committed to supporting the health needs of women through every stage of life. Theramex have helped millions of women around the world live better lives. Theramex believes in empowering women to make informed decisions about how to manage the natural cycles and stages of their life.
Pharmanovia
Pharmanovia is a global lifecycle management healthcare company. Their purpose is to make medicines fit for tomorrow, to improve the lives of patients globally.
They do this by enhancing established medicines by rediscovering, repurposing or re-engineering iconic brands to improve patient outcomes and experiences both through in-house development and strategic partnerships.
Their diverse and growing team operates in over 160 countries across the globe, delivering high-quality solutions, ethically and sustainably, across their four core therapeutic areas – Endocrinology, Neurology, Cardiovascular and Oncology.
Nordic Pharma
Nordic Pharma is a privately owned, medium-size international pharmaceutical company which focuses on the development and commercialization of specialty products. Portfolio enhancement has been accomplished through targeted developments and focused acquisitions to build a foundation in Ophthalmology, Rheumatology and Women’s Health. Nordic Pharma has established deep roots throughout Europe, and more recently, expanded outside of Europe with increased acquisitions worldwide.
Nordic Group is a part of SEVER Life Sciences, a holding company created in 2019 that brings together three diverse but complementary companies that offer a wide range of products, pharmaceutical development services and delivery technologies.
Sol-Gel
Sol-Gel Technologies Ltd is a dermatology company that carries out the identification, development and commercialization of investigational topical drug products for the treatment of skin diseases. Sol-Gel provides products under the brand name Epsolay® for the treatment of inflammatory lesions of rosacea in adults and Twyneo® for the treatment of acne vulgaris. Sol-Gel utilizes silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs. Sol-Gel was successful in developing pioneer topical drugs, Twyneo® and Epsolay®, for the treatment of acne and inflammatory lesions of rosacea.
Epsolay® utilizes proprietary technology in order to encapsulate benzoyl peroxide within silica-based microcapsules to create a barrier between the medication and the skin. The silica-based shell is designed to slowly release benzoyl peroxide over time to provide a favorable efficacy and safety profile.
Twyneo® is topical cream containing a fixed-dose combination of tretinoin and benzoyl peroxide, 0.1% / 3%, for the treatment of acne vulgaris in adults and pediatric patients nine years of age and older. TWYNEO is the first acne treatment that contains a fixed-dose combination of benzoyl peroxide and tretinoin. Tretinoin and benzoyl peroxide have a complementary mechanism of action and are widely prescribed separately for acne vulgaris; however, benzoyl peroxide causes degradation of the tretinoin molecule, thereby potentially reducing its effectiveness if used at the same time or combined in the same formulation. TWYNEO uses silica (silicon dioxide) core shell structures to separately micro-encapsulate tretinoin crystals and benzoyl peroxide crystals enabling inclusion of the two active ingredients in the cream.
